← Back to Search

Other

Low-Level Laser Therapy for Plantar Fasciitis

N/A
Recruiting
Research Sponsored by The Geneva Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have experienced symptoms of PF for at least 3 months
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-month
Awards & highlights

Study Summary

This trial aims to evaluate a new therapy to reduce pain and disability from foot injury in service members. Results will help inform best practices for treating foot-related issues.

Who is the study for?
Active-duty military members with a healthcare provider's diagnosis of Plantar Fasciitis, experiencing foot pain for at least 3 months, and able to commit to a 6-week treatment plus follow-ups. Excludes pregnant individuals, those on light/heat-sensitive meds or pacemakers, prior invasive treatments for the condition, significant tattoos/scarring on calves, neuropathy sufferers, and participants in other pain studies.Check my eligibility
What is being tested?
The trial is testing Photobiomodulation Therapy (PBMT) against Sham-PBMT to see if PBMT can improve foot function and reduce pain more effectively. Up to 100 service members will be randomly assigned to either group and monitored over time for changes in foot function, pain levels, and plantar fascial thickness.See study design
What are the potential side effects?
While specific side effects are not listed for PBMT or Sham-PBMT in this summary, potential risks may include skin warming due to light absorption which could lead to overheating of the skin especially where there is tattoo ink or scarring.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had symptoms of pulmonary fibrosis for at least 3 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Baseline Data Collection CRF
Baseline Data Collection CRF (Fitzpatrick Skin Phototype)
Demographic Information
+3 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: The Usual Care + PBM GroupActive Control1 Intervention
Participants that are assigned to this group will receive active treatment with PBM 3 times a week for 3 weeks for a total of 9 treatments.
Group II: The Usual Care + Sham (Placebo) PBM GroupPlacebo Group1 Intervention
Participants that are assigned to this group will receive Sham PBM therapy 3 times a week for 3 weeks for a total of 9 treatments. Sham PBM therapy is an inactive harmless treatment that is intended to mimic the active PBM treatment.

Find a Location

Who is running the clinical trial?

Musculoskeletal Injury Rehabilitation Research for Operational ReadinessFED
3 Previous Clinical Trials
410 Total Patients Enrolled
The Geneva FoundationLead Sponsor
30 Previous Clinical Trials
12,294 Total Patients Enrolled
Uniformed Services University of the Health SciencesFED
116 Previous Clinical Trials
91,316 Total Patients Enrolled

Media Library

Photobiomodulation Therapy (PBMT) (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05763381 — N/A
Plantar Fasciitis Research Study Groups: The Usual Care + PBM Group, The Usual Care + Sham (Placebo) PBM Group
Plantar Fasciitis Clinical Trial 2023: Photobiomodulation Therapy (PBMT) Highlights & Side Effects. Trial Name: NCT05763381 — N/A
Photobiomodulation Therapy (PBMT) (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05763381 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the participant population for this experiment restricted to those older than 35?

"This clinical trial stipulates that the minimum age of participants is 18, while those over 54 years old are not eligible for inclusion."

Answered by AI

Who has the suitable criteria to be considered for enrollment in this research study?

"This study has stringent eligibility criteria; the ideal candidate must have a diagnosis of plantar fasciitis, and be younger than 55 years old. The trial aims to enroll 100 volunteers in total."

Answered by AI

Are there any remaining participation opportunities for subjects in this trial?

"Affirmative. The data published on clinicaltrials.gov suggests that this study, which was initially advertised on August 11th 2022 and has been recently updated in March 8th 2023, is actively looking for 100 patients at a single site."

Answered by AI

What is the cap for participants in this experiment?

"Affirmative. According to clinicaltrials.gov, the current recruitment phase is active with postings beginning on August 11th 2022 and being recently updated on March 8th 2023. This medical research requires 100 participants from a single location."

Answered by AI
~37 spots leftby Mar 2025